DE69637154D1 - Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins - Google Patents
Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteinsInfo
- Publication number
- DE69637154D1 DE69637154D1 DE69637154T DE69637154T DE69637154D1 DE 69637154 D1 DE69637154 D1 DE 69637154D1 DE 69637154 T DE69637154 T DE 69637154T DE 69637154 T DE69637154 T DE 69637154T DE 69637154 D1 DE69637154 D1 DE 69637154D1
- Authority
- DE
- Germany
- Prior art keywords
- protein
- streptavidine
- compounds
- preparation
- highly efficient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
- A61K47/6897—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
- A61K47/6898—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies using avidin- or biotin-conjugated antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nanotechnology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/566,421 US6497881B1 (en) | 1995-11-30 | 1995-11-30 | High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
US566421 | 1995-11-30 | ||
PCT/US1996/018873 WO1997019957A1 (en) | 1995-11-30 | 1996-11-26 | High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69637154D1 true DE69637154D1 (de) | 2007-08-16 |
DE69637154T2 DE69637154T2 (de) | 2008-03-13 |
Family
ID=24262817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69637154T Expired - Lifetime DE69637154T2 (de) | 1995-11-30 | 1996-11-26 | Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins |
Country Status (10)
Country | Link |
---|---|
US (3) | US6497881B1 (de) |
EP (1) | EP0868435B1 (de) |
JP (1) | JP4124482B2 (de) |
AT (1) | ATE366120T1 (de) |
AU (1) | AU1060397A (de) |
DE (1) | DE69637154T2 (de) |
DK (1) | DK0868435T3 (de) |
ES (1) | ES2289754T3 (de) |
PT (1) | PT868435E (de) |
WO (1) | WO1997019957A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6497881B1 (en) * | 1995-11-30 | 2002-12-24 | New York University | High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
DE19735105A1 (de) * | 1997-08-13 | 1999-03-04 | Univ Albert Ludwigs Freiburg | Transportsystem zur Einbringung von Proteinen in Zielzellen mit Hilfe eines Fusionsproteins, Nucleinsäurekonstrukte kodierend für die Komponenten des Transportsystems und Arzneimittel, die Komponenten des Transportsystems umfassen |
PT1056850E (pt) * | 1998-02-23 | 2004-12-31 | Ark Therapeutics Ltd | Moleculas receptoras de ligacao a biotina |
US6380364B1 (en) | 1998-11-23 | 2002-04-30 | Loyola University Of Chicago | Chimeric biotin-binding papillomavirus protein |
US7144991B2 (en) | 1999-06-07 | 2006-12-05 | Aletheon Pharmaceuticals, Inc. | Streptavidin expressed gene fusions and methods of use thereof |
CA2376192A1 (en) * | 1999-06-07 | 2000-12-14 | Neorx Corporation | Streptavidin expressed gene fusions and methods of use thereof |
AU6607100A (en) * | 1999-07-23 | 2001-02-13 | Regents Of The University Of California, The | Anti-growth factor receptor avidin fusion proteins as universal vectors for drugdelivery |
EP1513543B1 (de) | 2002-05-23 | 2010-10-06 | The Trustees of The University of Pennsylvania | Fas peptid-mimetika und ihre verwendungszwecke |
ATE536367T1 (de) * | 2004-02-20 | 2011-12-15 | Univ Pennsylvania | Bindende peptidomimetika und deren verwendungen |
WO2006070416A1 (en) * | 2004-12-30 | 2006-07-06 | Fondazione Santa Lucia I.R.C.C.S. | An immunoprecipitation-based method to purify and characterise biological macromolecular complexes |
HUE032930T2 (hu) | 2007-11-12 | 2017-11-28 | Chreto Aps | Kettõs affinitású polipeptidek tisztításhoz |
EA034333B1 (ru) | 2010-11-30 | 2020-01-29 | Дженентек, Инк. | Варианты антитела для переноса соединения через гематоэнцефалический барьер |
US9623117B2 (en) * | 2011-04-04 | 2017-04-18 | Wisconsin Alumni Research Foundation | Method for selective targeting and entry of bacterial toxins to cells |
AU2015341081A1 (en) | 2014-10-28 | 2017-06-08 | Merck Patent Gmbh | Methods for non-covalent Fc-domain-containing protein display on the surface of cells and methods of screening thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4664911A (en) * | 1983-06-21 | 1987-05-12 | Board Of Regents, University Of Texas System | Immunotoxin conjugates employing toxin B chain moieties |
GB8813527D0 (en) * | 1988-06-08 | 1988-07-13 | Glennie M J | Bispecific antibodies |
US5407653A (en) * | 1991-06-26 | 1995-04-18 | Brigham And Women's Hospital | Evaluation of the multidrug resistance phenotype |
US5328985A (en) | 1991-07-12 | 1994-07-12 | The Regents Of The University Of California | Recombinant streptavidin-protein chimeras useful for conjugation of molecules in the immune system |
PT627940E (pt) * | 1992-03-05 | 2003-07-31 | Univ Texas | Utilizacao de imunoconjugados para o diagnostico e/ou terapia de tumores vascularizados |
GB9300686D0 (en) | 1993-01-15 | 1993-03-03 | Imp Cancer Res Tech | Compounds for targeting |
JPH11510050A (ja) | 1995-07-25 | 1999-09-07 | イントロヘーネ ベスローテン フェンノートシャップ | 標的遺伝子送達のための方法および手段 |
US6497881B1 (en) * | 1995-11-30 | 2002-12-24 | New York University | High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
-
1995
- 1995-11-30 US US08/566,421 patent/US6497881B1/en not_active Expired - Fee Related
-
1996
- 1996-11-26 AT AT96941471T patent/ATE366120T1/de not_active IP Right Cessation
- 1996-11-26 EP EP96941471A patent/EP0868435B1/de not_active Expired - Lifetime
- 1996-11-26 AU AU10603/97A patent/AU1060397A/en not_active Abandoned
- 1996-11-26 DE DE69637154T patent/DE69637154T2/de not_active Expired - Lifetime
- 1996-11-26 PT PT96941471T patent/PT868435E/pt unknown
- 1996-11-26 DK DK96941471T patent/DK0868435T3/da active
- 1996-11-26 JP JP52059397A patent/JP4124482B2/ja not_active Expired - Fee Related
- 1996-11-26 WO PCT/US1996/018873 patent/WO1997019957A1/en active IP Right Grant
- 1996-11-26 ES ES96941471T patent/ES2289754T3/es not_active Expired - Lifetime
-
2002
- 2002-11-06 US US10/289,921 patent/US20030113337A1/en not_active Abandoned
-
2008
- 2008-12-15 US US12/335,010 patent/US20090098148A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK0868435T3 (da) | 2007-11-05 |
JP4124482B2 (ja) | 2008-07-23 |
ATE366120T1 (de) | 2007-07-15 |
ES2289754T3 (es) | 2008-02-01 |
PT868435E (pt) | 2007-10-01 |
WO1997019957A1 (en) | 1997-06-05 |
DE69637154T2 (de) | 2008-03-13 |
EP0868435A4 (de) | 2001-04-04 |
JP2000502885A (ja) | 2000-03-14 |
AU1060397A (en) | 1997-06-19 |
EP0868435B1 (de) | 2007-07-04 |
US20090098148A1 (en) | 2009-04-16 |
EP0868435A1 (de) | 1998-10-07 |
US6497881B1 (en) | 2002-12-24 |
US20030113337A1 (en) | 2003-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69637154D1 (de) | Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins | |
DE69637867D1 (de) | Verfahren zur Kontrollierung der Sialylierung von durch Säugetierzellkultur hergestellten Proteinen | |
DE122009000068I2 (de) | Verfahren zur Herstellung von heterologen bispezifischen Antikörpern | |
PL352332A1 (en) | Expression and export of interferon-alpha proteins as fc fusion proteins | |
IL173399A0 (en) | Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy | |
ATE400651T1 (de) | Verwendung von grünem fluoreszenzprotein | |
ATE414162T1 (de) | Verfahren und materialien zur herstellung von glucosamin | |
DK0866876T3 (da) | Fremgangsmåde til fremstilling af rekombinante proteiner i E.coli ved hjælp af fermentering i høje celletætheder | |
WO1996021007A3 (en) | Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells | |
ATE135371T1 (de) | Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis | |
DE69735264D1 (de) | Gefrierschutzproteine aus choristoneura sp., gene und verfahren zu ihrer verwendung | |
FR2560212B1 (fr) | Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps | |
DE69332471T2 (de) | Verfahren zur herstellung modifizierten proteine | |
JPS61275229A (ja) | ヒト血清アルブミンの微生物学的調製法 | |
MX9603266A (es) | Genes de timocina de mamiferos. | |
ATE332974T1 (de) | Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung | |
DE69613685D1 (de) | D-aminosäure-oxidase kodierendes dns-fragment | |
EP0888374A4 (de) | Nukleinsäureliganden mit hoher affinität für die proteine des komplementsystems | |
DE60040789D1 (de) | Verfahren zur aufreinigung heterologer proteine | |
ATE379967T1 (de) | Nukleinsäuren kodierend miteinander verbundene chromo/fluoreszenzdomänen und verfahren zu ihrer verwendung | |
DE69930118D1 (de) | Verfahren zur herstellung von proteinen in transformierten hefezellen | |
DE60233347D1 (de) | Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung | |
WO2000034335A3 (en) | 'death domain' containing receptors | |
DE69923595D1 (de) | Herstellung von proteinen | |
MX9700255A (es) | Metodo para identificar acidos nucleicos que codifican las proteinas activadoras del promotor c-fos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |